Tril stock price

Trillium Therapeutics stock price history + stock price today + stock chart + seasonality chart + earnings + dividends + century-to-date Dogs of the Dow beating  Real-time share price updates and latest news for Trillium Therapeutics Inc ( NASDAQ:TRIL). Compare across sectors, industries & regions. T R I L Live NSE/BSE Share Price: Get T R I L Stock Price details, News, Financial Results, Stock Charts, Returns, Research Reports and more. 16 hours ago [TRIL] has 74.97M shares outstanding, amounting to a total market cap of 299.87 M. Its stock price has been found in the range of 0.24 to 7.97. At  20 Feb 2020 (TSE:TRIL) share price has soared 211% return in just a single year. Shareholders are also celebrating an even better 1016% rise, over the last 

Analyzing Trillium Therapeutics (TSE:TRIL) stock? View TRIL's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat.

In depth view into TRIL (Trillium Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. TRIL - Trillium Therapeutics Inc. Summary, Stock Quote and ... Jan 01, 2010 · Trade TRIL stock for free with recommended broker TD Benzinga Newsdesk Mon, Trillium Therapeutics Regains Compliance With Nasdaq Minimum Bid Price … Trillium Therapeutics Inc. (TRIL) stock price, quote ... As of late, it has definitely been a great time to be an investor in Trillium Therapeutics Inc. (TRIL). January has turned out great for biotech stocks thanks to the coronavirus outbreak as well as a general upbeat trend. Investors need to pay close attention to Trillium (TRIL) stock based on the TRIL – Stock quote for Trillium Therapeutics Inc – MSN Money

View the latest TRIL stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of Trillium Therapeutics Inc.

Get breaking news and analysis on Trillium Therapeutics Inc. (TRIL) stock, price quote and chart, trading and investing tools. TRIL Trillium Therapeutics Inc. daily Stock Chart Jan-16-20 08:00AM, Trillium Therapeutics Regains Compliance With Nasdaq Minimum Bid Price